Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:04:17 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



T:APLI - APPILI THERAPEUTICS INC. J - http://www.appilitherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
APLI - T  263.00.035·0.04244.00.035-0.005-12.518.7170.04  0.04  0.0350.08  0.02513:17:06Apr 0215 min RT 2¢
TSX - T263.00.035·0.04244.00.043.0010.04  0.04  0.040.08  0.02510:45:0015 min
Omega - O 0.035-0.005-12.515.0110.035  0.035  0.03513:17:0615 min
CXD - D 0.040.75    Apr 0515 min

Recent Trades - All 7 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
13:17:06O0.035-0.00515,0001 Anonymous1 AnonymousK
11:59:35D0.035-0.0055007 TD Sec124 QuestradeE
10:45:00T0.04 3,0001 Anonymous1 AnonymousKL
10:39:13D0.04 1507 TD Sec7 TD SecE
09:44:29D0.04 880 National Bank7 TD SecE
09:44:12D0.04 2380 National Bank2 RBCE
09:43:20D0.04 180 National Bank7 TD SecE
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-02 11:36C:APLI0.035News ReleaseAppili Therapeutics to be acquired by Aditxt
2024-03-12 10:04C:APLI0.035News ReleaseAppili researcher publishes manuscript on tularemia
2024-02-13 22:18C:APLI0.025SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-13 22:13C:APLI0.025SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-13 17:57C:APLI0.025News ReleaseAppili has Dec. 31 cash position of $600,000
2023-12-15 10:13C:APLI0.04News ReleaseAppili Therapeutics partner receives ATI-1701 patent
2023-11-14 15:57C:APLI0.035SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 15:55C:APLI0.035SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-13 16:46C:APLI0.035News ReleaseAppili has Sept. 30 cash position of $400,000
2023-10-25 10:08C:APLI0.035News ReleaseAppili to receive further funding for ATI-1701
2023-09-27 19:27C:APLI0.055News ReleaseAppili shareholders approve all matters at AGM
2023-09-25 10:30C:APLI0.065News ReleaseAppili partner receives U.S. FDA OK for ATI-1501
2023-08-11 18:30C:APLI0.045SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-11 17:01C:APLI0.045News ReleaseAppili Therapeutics has cash of $500,000 at June 30
2023-06-29 12:46C:APLI0.04News ReleaseAppili Therapeutics arranges $300,000 bridge loan
2023-06-23 10:28C:APLI0.035News ReleaseAppili has cash of $2.5-million at end of fiscal 2023
2023-06-23 09:14C:APLI0.035SEDAR Annual Information FormSEDAR Annual Information Form
2023-06-23 08:54C:APLI0.035SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-06-23 08:05C:APLI0.035SEDAR MD & ASEDAR MD & A
2023-05-24 10:05C:APLI0.04News ReleaseAppili Therapeutics receives U.S. patent for ATI-1501